Ultragenyx says gene therapy accepted for FDA review again.
Share this article
Earnings
Score 45
Bullish
Ultragenyx says gene therapy accepted for FDA review again
Apr 02, 2026 13:31 UTC
UG, ^GSPC, ^IXP
Short term
Related Articles
Score 25
Eaton Vance Floating-Rate Income Trust declares $0.069 dividend
Apr 02, 15:11
Score 35
S&P 500 Briefly Turns Positive Amid Oil Price Pullback
Apr 02, 15:09
Score 75
Bullish
Iran Signals Cooperation on Hormuz Strait, Boosts Markets and Crypto
Apr 02, 15:08
Score 25
Keysight launches virtual assembly simulation software
Apr 02, 15:04
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.